AIDS and Behavior

, Volume 10, Issue 3, pp 253–261 | Cite as

The Differential Impact of PTSD and Depression on HIV Disease Markers and Adherence to HAART in People Living with HIV

  • Jessica M. Boarts
  • Eve M. Sledjeski
  • Laura M. Bogart
  • Douglas L. Delahanty
Article

Despite high rates of comorbidity, research has typically focused on the independent impact of posttraumatic stress disorder (PTSD) and depression symptoms in people living with HIV (PLWH). The present study examined the independent and comorbid influence of PTSD and depression symptoms on medication adherence, CD4 cell counts, and viral load, over the course of 3 months in 57 PLWH (82% men, 54% Caucasian, 44% African American) recruited from a clinic or social service agency. Both PTSD and depressive symptoms predicted lower subsequent adherence. However, only depressive symptoms predicted lower CD4 counts and presence of a detectable viral load. Participants reporting symptoms consistent with diagnostic levels of comorbid PTSD and depression were less likely to adhere to HAART and were more likely to have a detectable viral load. These results highlight the influences of PTSD and depression on adherence and HIV disease markers, and underscore the importance of examining comorbid symptomatology in PLWH.

KEY WORDS:

HIV PTSD depression adherence CD4 viral load. 

REFERENCES

  1. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.Google Scholar
  2. Ammassari, A., Antinori, A., Aloisi, M. S., Trotta, M. P., Murri, R., Bartoli, L., et al. (2004). Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons. Psychosomatics, 45 394–402.CrossRefPubMedGoogle Scholar
  3. Bangsberg, D. R., Hecht, F. M., Charlebois, E. D., Chesney, M. A., and Moss, A. (2001). Comparing objective measures of adherence to HIV antiretroviral therapy: Electronic medication monitors and unannounced pill counts. AIDS and Behavior, 5 275–281.CrossRefGoogle Scholar
  4. Bangsberg, D. R., Hecht, F. M., Charlebois, E. D., Zolopa, A. R., Holodniy, M., Sheiner, L., et al. (2000). Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS, 14 357–366.CrossRefPubMedGoogle Scholar
  5. Breslau, N., Davis, G., Andreski, P., Federman, B., and Anthony, J. (1998). Epidemiological findings on posttraumatic stress disorder and co-morbid disorders in the general population. In B. P. Dohrenwend (Ed.), Adversity, stress, & psychopathology (pp. 319–330). London: Oxford University Press.Google Scholar
  6. Breslau, N., Davis, G. C., Andreski, P., Peterson, E. L., and Schultz, L. R. (1997). Sex differences in posttraumatic stress disorder. Archives of General Psychiatry, 54 1044–1048.PubMedGoogle Scholar
  7. Catz, S. L., Kelly, J. A., Bogart, L. M., Benotsch, E. G., and McAuliffe, T. (2000). Patterns, predictors, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychology, 19 124–133.CrossRefPubMedGoogle Scholar
  8. Chandra, P. S., Ravi, V., Desai, A., and Subbakrishna, D. K. (1998). Anxiety and depression among HIV-infected heterosexuals—A report from India. Journal of Psychosomatic Research, 45 401–409.CrossRefPubMedGoogle Scholar
  9. Chesney, M. A., Ickovics, J. R., Chambers, D. B., Gifford, A. L., Neidig, J., Zwickl, B., et al. (2000). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care, 12 255–266.CrossRefPubMedGoogle Scholar
  10. Cohen, M. A., Alfonso, C. A., Hoffman, R. G., Milau, V., and Carrera, G. (2001). The impact of PTSD on treatment adherence in persons with HIV infection. General Hospital Psychiatry, 23 294–296.CrossRefPubMedGoogle Scholar
  11. Delahanty, D. L., Bogart, L. M., and Figler, J. L. (2004). Posttraumatic stress disorder symptoms, salivary cortisol, medication adherence, and CD4 levels in HIV-positive individuals. AIDS Care, 16 247–260.CrossRefPubMedGoogle Scholar
  12. Foa, E. B., Cashman, L., Jaycox, L., and Perry, K. (1997). The validation of a self-report measure of posttraumatic stress disorder: The posttraumatic diagnostic scale. Psychological Assessment, 9 445–451.CrossRefGoogle Scholar
  13. Fulk, L. J., Kane, B. E., Phillips, K. D., Bopp, C. M., and Hand, G. A. (2004). Depression in HIV-infected patients allopathic, complementary, and alternative treatments. Journal of Psychosomatic Research, 57 339–351.PubMedGoogle Scholar
  14. Gielen, A. C., McDonnell, K. A., Wu, A. W., O’Campo, P., and Faden, R. (2001). Quality of life among women living with HIV: The importance of violence, social support, and self care behaviors. Social Science and Medicine, 52 315–322.CrossRefPubMedGoogle Scholar
  15. Gonzalez, J. S., Penedo, F. J., Antoni, M. H., Duran, R. E., Fernandez, M. I., McPherson-Baker, S., et al. (2004). Social support, positive states of mind, and HIV treatment adherence in men and women living with HIV/AIDS. Health Psychology, 23 413–418.CrossRefPubMedGoogle Scholar
  16. Gordillo, V., del Almo, J., Soriano, V., and Gonzalez-Lahoz, J. (1999). Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS, 13 1763–1769.CrossRefPubMedGoogle Scholar
  17. Gore-Felton, C., Butler, L. D., and Koopman, C. (2001). HIV disease, violence, and post-traumatic stress. Focus, 16 5–6.PubMedGoogle Scholar
  18. Gore-Felton, C., and Koopman, C. (2002). Traumatic experiences: Harbinger of risk behavior among HIV-positive adults. Journal of Trauma and Dissociation, 3 121–135.CrossRefGoogle Scholar
  19. Ickovics, J. R., Hamburger, M. E., Vlahov, D., Schoenbaum, E. E., Schuman, P., Boland, R. J., et al. (2001). Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women. JAMA, 285 1466–1474.CrossRefPubMedGoogle Scholar
  20. Kalichman, S. C., Difonzo, K., Austin, J., Luke, W., and Rompa, D. (2002). Prospective study of emotional reactions to changes in HIV viral load. AIDS Patient Care and STDs, 16 113–120.CrossRefPubMedGoogle Scholar
  21. Katz, M. R., Kopek, N., Waldron, J., Devins, G. M., and Tomlinson, G. (2004). Screening for depression in head and neck cancer. Psycho-Oncology, 13 269–280.CrossRefPubMedGoogle Scholar
  22. Kelly, B., Raphael, B., Judd, F., Perdices, M., Kernutt, G., Burnett, P., et al. (1998). Posttraumatic stress disorder in response to HIV infection. General Hospital Psychiatry, 20 345–352.CrossRefPubMedGoogle Scholar
  23. Kessler, R. C., Sonnega, A., Bromet, E., Hughes, M., and Nelson, C. B. (1995). Posttraumatic stress disorder in the National Comorbidity Survey. Archives of General Psychiatry, 52 1048–1060.PubMedGoogle Scholar
  24. Kimerling, R., Armistead, L., and Forehand, R. (1999a). Victimization experiences and HIV infection in women: Associations with serostatus, psychological symptoms, and health status. Journal of Traumatic Stress, 12 41–58.CrossRefPubMedGoogle Scholar
  25. Kimerling, R., Calhoun, K. S., Forehand, R., Armistead, L., Morse, E., Morse, P., et al. (1999b). Traumatic stress in HIV-infected women. AIDS Education and Prevention, 11 321–330.PubMedGoogle Scholar
  26. Knobel, H., Guelar, A., Carmona, A., Espona, M., Gonzalez, A., Lopez-Colomes, J. L., et al. (2001). Virologic outcomes and predictors of virologic failure of highly active antiretroviral therapy containing protease inhibitors. AIDS Patient Care and STDs, 15 193–199.CrossRefPubMedGoogle Scholar
  27. Komiti, A., Judd, F., Grech, P., Mijch, A., Hoy, J., Williams, B., et al. (2003). Depression in people living with HIV/AIDS attending primary care and outpatient clinics. Australian and New Zealand Journal of Psychiatry, 37 70–77.CrossRefPubMedGoogle Scholar
  28. Kuritzkes, D. R. (2001). Clinical implications for antiretroviral resistance. HIV Clinical Management, V13. Retrieved from http://www.medscape.comGoogle Scholar
  29. Leserman, J. (2003a). HIV disease progression: Depression, stress, and possible mechanisms. Biological Psychiatry, 54 295–306.CrossRefPubMedGoogle Scholar
  30. Leserman, J. (2003b). The effects of stressful life events, coping, and cortisol on HIV infection. CNS Spectrums, 8 25–30.PubMedGoogle Scholar
  31. Leserman, J., Petitto, J. M., Gu, H., Gaynes, B. N., Barroso, J., Golden, R. N., et al. (2002). Progression to AIDS, a clinical AIDS condition, and mortality: Psychosocial and physiological predictors. Psychological Medicine, 32 1059–1073.CrossRefPubMedGoogle Scholar
  32. Low-Beer, S., Yip, B., O’Shaughnessy, M. V., Hogg, R. S., and Montaner, J. S. (2000). Adherence to triple therapy and viral load response. Journal of Acquired Immune Deficiency Syndrome, 23 360–361.Google Scholar
  33. Martinez, A., Israelski, B. S., Walker, C., and Koopman, C. (2002). Posttraumatic stress disorder in women attending human immunodeficiency virus outpatient clinics. AIDS Patient Care and STDs, 16 283–291.CrossRefPubMedGoogle Scholar
  34. Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., et al. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133 21–30.PubMedGoogle Scholar
  35. Pradier, C., Carrieri, P., Bentz, L., Spire, B., Dellamonica, P., Moreau, J., et al. (2001). Impact of short-term adherence on virological and immunological success of HAART: A case study among French HIV-infected IDUs. International Journal of STDs and AIDS, 12 324–328.CrossRefGoogle Scholar
  36. Rabkin, J. G. (1996). Prevalence of psychiatric disorders in HIV illness. International Review of Psychiatry, 8 157–166.CrossRefGoogle Scholar
  37. Radloff, L. S. (1977). The CES-D scale: A new self-report depression scale for research in the general population. Applied Psychological Measurement, 1 385–401.CrossRefGoogle Scholar
  38. Ricart, F., Cohen, M. A., Alfonso, C. A., Hoffman, R. G., Quinones, N., Cohen, A., et al. (2002). Understanding the psychodynamics of non-adherence to medical treatment in persons with HIV infection. General Hospital Psychiatry, 24 176–180.CrossRefPubMedGoogle Scholar
  39. Safren, S. A., Gershuny, B. S., and Hendriksen, E. (2003). Symptoms of posttraumatic stress and death anxiety in persons with HIV and medication adherence difficulties. AIDS Patient Care and STDS, 17 657–664.CrossRefPubMedGoogle Scholar
  40. Safren, S. A., Otto, M. W., Worth, J. L., Salomon, E., Johnson, W., Mayer, K., et al. (2001). Two strategies to increase adherence to HIV antiretroviral medication: Life-steps and medication monitoring. Behaviour Research and Therapy, 39 1151–1162.CrossRefPubMedGoogle Scholar
  41. Schuman, P., Ohmit, S. E., Cohen, M., Sacks, H. S., Richardson, J., Young, M., et al. (2001). Prescription of and adherence to antiretroviral therapy among women with AIDS. AIDS and Behavior, 5 371–378.CrossRefGoogle Scholar
  42. Sethi, A. K., Celentano, D. D., Gange, S. J., Moore, R. D., and Gallant, J. E. (2003). Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance. Clinical Infectious Diseases, 37 1112–1118.CrossRefPubMedGoogle Scholar
  43. Sledjeski, E. M., Delahanty, D. L., and Bogart, L. M. (2005). Incidence and impact of posttraumatic stress disorder and comorbid depression on adherence to HAART and CD4 counts in people living with HIV. AIDS Patient Care and STDs, 19 26–34.CrossRefGoogle Scholar
  44. Smith, M. Y., Egert, J., Winkel, G., and Jacobson, J. (2002). The impact of PTSD on pain experience in persons with HIV/AIDS. Pain, 98 9–17.CrossRefPubMedGoogle Scholar
  45. Spiegel, D., Israelski, D. M., Power, R., Prentiss, D. E., Balmas, G., Muhammad, M., et al. (2003). Acute stress disorder, PTSD, and depression in a clinic-based sample of patients with HIV/AIDS. Journal of Psychosomatic Research, 55 128.CrossRefGoogle Scholar
  46. Wood, E., Hogg, R. S., Yip, B., Harrigan, P. R., O’Shaughnessy, M. V., and Montaner, J. S. (2003). Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350 × 10(9) cells/L. Annals of Internal Medicine, 139 810–816.PubMedGoogle Scholar
  47. Zierler, S., Cunningham, W. E., Andersen, R., Shapiro, M. F., Bozzette, S. A., Nakazono, T., et al. (2000). Violence victimization after HIV infection in a US probability sample of adult patients in primary care. American Journal of Public Health, 90 208–215.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2006

Authors and Affiliations

  • Jessica M. Boarts
    • 1
  • Eve M. Sledjeski
    • 1
  • Laura M. Bogart
    • 2
  • Douglas L. Delahanty
    • 1
    • 3
    • 4
  1. 1.Department of PsychologyKent State UniversityKentUSA
  2. 2.RAND CorporationSanta MonicaUSA
  3. 3.Department of Psychology in PsychiatryNortheastern Ohio Universities College of Medicine (NEOUCOM)RootstownUSA
  4. 4.Department of PsychologyKent State UniversityKentUSA

Personalised recommendations